• HealthCare21
    We develop novel medical communications for pharmaceutical companies
    Providing essential support for their treatments
  • HealthCare21
    Creating an impactful fusion by combining
    science with the latest technology
    To develop interactive medical education
    activities For professionals and Patients
    engaging peer-
    to-peer workshops...
    eLearning Platforms
  • HealthCare21
    Alternatively you can call us on
    01625 503 479
  • HealthCare21
    A bespoke service
    One integrated team
    Your trusted partner
  • HealthCare21

The perfect blend of science and technology

Communicating with medical audiences across complex specialist care areas can be challenging: you need excellent content, a tailored use of technology and an engaging educational approach.

HealthCare21 is an independent strategic medical communications company supporting pharmaceutical companies active in speciality therapeutic areas through the development of highly relevant, technology-rich educational programmes and tools.

Our team combines strong scientific understanding and content development with a depth of technical know-how and many years’ international experience.

Our service is personal, flexible and highly engaged.

We think you will like our approach, our ideas and the impact we can make for you.


DOL Thumb

Our Latest Thinking

With the ever growing demand for digital learning and social media in healthcare, digital opinion leaders (DOLs) have now arrived on the multichannel scene. DOLs include HCPs who are influential members of an online community (around 30%) to whom others turn to for advice, opinion and information. DOLs have a growing number of followers and generate a lot of, usually very disease specific and highly relevant content which is actively shared.

Preview the video



Upcoming Events


    Washington DC, USA
    Sep 14th - 15th
  • BASL

    Coventry, UK
    Sep 20th - 22nd
  • ECC

    Budapest, Hungary
    Oct 16th - 18th
  • HGC

    Toronto, Canada
    Oct 20th - 21st

    Washington DC, USA
    Oct 20th - 24th

    Paris, France
    Oct 25th - 28th

    San Diego, USA
    Nov 3rd - 8th
  • IPIC

    Dubai, UAE
    Nov 8th - 10th
  • AHA

    California, USA
    Nov 11th - 15th
  • IDF

    Abu Dhabi, UAE
    Dec 4th - 8th
  • ASH

    Georgia, USA
    Dec 9th - 12th

When thinking about my medical communications partner I am looking for…

Well-grounded recommendations based on successful approaches that deliver measurable impact

Strong content development skills within my therapy areas

A team with international experience and strategic insights into the dynamics that influence behaviour

Creative educational approaches with innovative and integrated multichannel thinking

Value for money and return on investment

A self-guided, proactive and flexible team who is able to share ideas and engage with my company at all levels


| What We Do

We focus on answering your needs with a bespoke, flexible and highly engaged service. The established team rapidly become an integral element in your company to produce a seamless collaboration and help you create the best possible outcome.

We refuse to produce anything that does not reflect our greatest efforts, highest quality and years of experience – ‘satisfactory’ isn’t in our nature. Our aim is to mirror your aim, but more than that, we always think one step ahead and how we can help you achieve the optimum benefit and maximise your outreach. HealthCare21 tackle challenges head-on, offer solutions and remain proactive in everything we do.

Engaging Live Audiences

Compliant Social Media Use

Empowering Patients

Improving Clinical Practice

Immersive & Experiential Learning

Expert Engagement

Clinical Positioning

Informed Patient Decision-Making

Telehealth & Patient Self-Management

customer insights

strategy planning


Compliant social media use

Healthcare professionals, payors, patients and carers are online looking for relevant, accurate and tailored information (resources, peer opinion and shared experiences).

Social media can enable users to efficiently find specific valuable information and the pharmaceutical industry is being encouraged to use social media to communicate information about how their products can improve patient care. Often, regulatory and compliance measures present as a challenge, particularly when a two-way exchange of information is involved, e.g., Twitter Chat Forums.

HC21 has an indepth knowledge of all relevant guidelines and policies impacting effective use of social media. We have developed individual and partnership approaches that are fully compliant and take into account measurable attitude and behavioural insights, such as addressing key touch points and information needs at different points along the care pathway for individuals with long-term conditions.

See our TEN TIPS FOR PHARMA to boost social media engagement; a round-up of the most successful and compliant uses of social media in the pharmaceutical industry.

Engaging live audiences

Directly involving attendees in the learning activity is key to any live event whether it be a symposium, forum, preceptorship or web-workshop.

Using on-demand, informative and intuitive communication tools to engage audiences is an important part of this learning process.

HC21 integrates a variety of its own open-source applications and dedicated partner products that are phone, tablet and laptop enabled. These are used pre-meeting to assess individual learning needs, provide pre-activity learning and introductory faculty videos; during meetings for polling, faculty questions, viewing sessions and slides, and post-activity to evaluate the learning, provide teaching slide sets, case studies and discussion summaries.

Collaborative strategic launch and lifecycle management planning

Involving relevant internal and external stakeholders in collaborative planning activities is key to strategic gap analysis and scenario planning.

We use a variety of integrated and iterative approaches to gain insights and examine clinical practice and gap analysis opportunities, explore educational and publication needs and to validate thinking. These assessments bring real-world practical perspectives to the planning process and get to grips with important market dynamics and clinical or launch/ lifecycle management programme requirements.
These include a range of digital and printed templates, poster exchanges, and magnetic board tools that can be applied at different times during the planning process to really engage participants and facilitate dialogue on the key issues and main drivers. HC21 is also experienced in facilitating these meetings and workshops in order to get the most from them and optimal participation from those involved.

Experiential learning and virtual preceptorships

The introduction of new treatment options into routine practice requires educational investment and customer support. Medical Scientific Liaison (MSL) team members take a key role in providing tailored support across a range of local implementation needs. Experiential mini-fellowship courses and virtual preceptorships provide valuable learning opportunities for MSLs and healthcare professionals (HCPs).

Experiential mini-fellowship courses undertaken at key clinical and academic centres of excellence involving expert faculty who have direct experience of the new treatment, through being involved at a clinical investigator site or as an early adopter, enable valuable clinical practice knowledge to be gained in key customer support areas. This might include administration and usage, development of local protocols, patient support and training of the care team. Importantly they provide patient pathway insights, for example, first-hand knowledge of what takes place in the clinic and the patient’s perspective on their condition or treatment. HCPs also gain valuable real-world experience through moderated patient interaction in the clinic.

HC21 has extended this successful approach to develop novel virtual preceptorships that aim to give the same patient-focused experience through documentary-style videos simulating interactions between actual care team members and patients at different stages of the pathway supported by expert-lead learning modules. This learning can be viewed on laptop, tablet or phone, can be undertaken at any time and has self-assessment and supporting links built in.

Gaining and integrating customer insights into brand and lifecycle management (LCM) planning

Gathering and assessing insights from all stakeholders, both external and internal, is key to shaping and
validating clinical development, medical affairs and commercial strategy planning

To gain real-world insight into research priorities, clinical paradigm and treatment strategy trends and LCM opportunities, patient pathway perspectives, unmet educational priorities, competitor developments, health economic barriers and practical aspects of patient management, HC21 routinely undertakes interviews with experts and stakeholder group representatives.

  • 30-minute individual recorded telephone or Skype interviews or 10-day group virtual advisory boards conducted with internal stakeholders and healthcare professionals (senior experts, active practitioners, rising stars)


  • A structured interview questionnaire is developed based on key gap analysis and PICO framework questions


  • Interviews are gained from all key regions and include established and developing markets to gain global perspective


  • Interviews are conducted in English and in local language for non-English speakers using a local interpreter and transcribed as necessary

Telehealth and patient self-management

Patients with long-term conditions that need specialist management can find their treatment needs impacting upon their everyday routines and incorporating clinical advice can be difficult.

For example, treatment side effects, lifestyle restrictions and susceptibility to further comorbidities are all aspects of a progressive condition that need to be considered over time.

Telehealth resources present an opportunity for patients to become more informed on self-management and interact with their healthcare team outside of scheduled appointments and can include anything from the facility to set up a phone call or video consult with their physician to an online diagnostic and medication log.

The impact of these resources is a more accurate view of a patient’s condition; real-time reporting provides a more truthful and holistic picture that can allow a healthcare professional to thoroughly review and meet the needs of the patient. For patients, telehealth enables issues and questions to be addressed quicker improving treatment compliance and self-management.

Watch the video on MYHEALTH MONITOR on the use of telehealth to engage patients and the wider care team outside of clinic visits.

Informed patient decision-making

Health literacy levels worldwide are inadequate, and patients are not taking an active-enough role in their own healthcare.

Low health literacy levels have been linked to substandard management of chronic conditions, uninformed treatment decisions and poor treatment compliance. The solution is to provide suitable and accessible educational content and offer perspectives from the point of view of both the patient and their healthcare team. This engages providers, patients and carers in active and ongoing dialogue during the care process, particularly with a focus on key touchpoints.

Based on provider and patient needs assessment surveys, HealthCare 21 provides the resources that allow for an improved dialogue between patients and their doctors using media ranging from downloadable web content, social media, records of care and self-help booklets. These resources pave the way for the patients to feel more confident in their healthcare process, thus generating interest in preventative measures and a stronger understanding of treatment options so that informed decisions can be made.

Also see TELEHEALTH & PATIENT SELF-MANAGEMENT for more details on activities to engage patients and the wider care team outside of clinic visits.

Clinical positioning of new treatment options

Careful clinical positioning of a new treatment option provides answers to important questions for healthcare professionals and patients.

Treatments are often now available in advance of clinical practice guideline updates. Clear clinical positioning is therefore necessary to ensure awareness and understanding for appropriate use within the care pathway. Translating evidence-based benefits into day-to-day clinical practice and tailoring this information for professionals, patients and carers is essential, particularly in increasingly complex long-term care areas where there are many facets to providing effective care and patient self-management.

Bringing multispecialty experts together to consider all aspects of clinical management, patient support, health economics and real-world outcomes measurement within an independent consensus forum has proved an effective way of addressing key questions.

The output from concensus forums include scientific papers and accompanying slides, association updates, peer-to-peer educational activities, videos and social media activities to disseminate the expert opinion/guidance to a wider audience.

See an example publication, slide set and video on atrial fibrillation and stroke prevention.

Expert engagement

Quantitative and qualitative assessment of clinicians, researchers, academics, pharmacists, payors and other stakeholders working in particular areas of healthcare is indispensable to ensure identification of key individuals for participation in advisory and peer-to-peer activities.

HealthCare21 has a tried and trusted methodology for undertaking this mapping which has been used to evaluate expertise in over 15 areas of care. It includes comprehensive desktop research, telephone interviews with experts and stakeholders and interviews with internal company team members.

Quantified content is included in an open source searchable and sortable Excel database (to enable selection of individuals for engagement activities) and comes with a number of standard reports and the option for customisable outputs. An accompanying slide set summarises the extensive information gathered in graphical form.

Immersive and experiential learning

The introduction of a new treatment option into routine practice requires extensive educational measures for all those involved in its use. Pharmaceutical companies, typically medical affairs team members, take a key role in this process providing customer support across a range of local implementation needs.

Immersive and experiential training courses undertaken at medical centres of excellence involving expert faculty who have direct experience of the new treatment through being a clinical investigator site or early adopter provide valuable insights.

For pharmaceutical team members, courses provide the opportunity to gain first-hand knowledge around key aspects in which they will need to provide customer support, e.g., administration and usage, patient support and training.

For healthcare professionals, valuable real-life experience is gained through moderated patient interaction and opportunity to observe and discuss care pathway improvements with experts in the field.

Courses are tailored to participant needs, are typically highly clinic based with supporting education provided through case discussion, grand rounds and workshop sessions. Interactive tools are used to help engage faculty and participants in the learning process.

Our Difference

Below we have included some of the feedback given to us by our clients about working with us. We have also listed some of our clients.

HealthCare21 - Lundbeck
HealthCare21 - Sanofi
HealthCare21 - Norgine
HealthCare21 - Novartis
HealthCare21 - Regeneron
HealthCare21 - Sobi
HealthCare21 - Pfizer
HealthCare21 - Pfizer
HealthCare21 - Pfizer
HealthCare21 - NHS
HealthCare21 - Intercept
HealthCare21 - Intercept

| Our Values

    We believe that:
  • our customers are precious
  • we should take responsibility for and always honour our obligations
  • open honest relationships are essential
  • authenticity and integrity are fundamental
  • simple is usually the best approach
  • limiting redundancy and waste is a priority
  • no questions are stupid
  • you have the right to your opinion and to speak your mind
  • good ideas come from everyone
  • sound corporate social responsibility should be part of daily activities.

We recognise and adopt the positive benefits of diversity
We are fully engaged with our clients and work together towards a common aim.
We deliver a tailored service which is of the highest quality and is good value for money
We draw upon the resources within our extended team to deliver effective and measurable solutions
We believe in positive, open and candid relationships
We work to proven processes and take full responsibility for our agreed deliverables

| Our News

We like to keep abreast of current new topics in the fields of healthcare, medical research, medicine, science, technology and digital developments. Here you will find short articles written by our team members on subjects that have really grabbed our attention.

Cancer Immunoediting
Tuesday, January 9, 2018
Dr Google Diagnosis
Thursday, January 4, 2018
HIV infection
Thursday, January 4, 2018
HIV infection
Myocardial Infarction
Thursday, January 4, 2018

| Contact Us

Find out more about cost-effective and focused programmes that provide an impact through consistent and coherent product messages, delivered to the right target audiences at the right time.

We will ensure that your critical customer contacts lead to positive product responses.